Dental Implant Surgery Statistics 2026: Volume, Success Rates, Cost & Failure
Dental implants are among the most successful procedures in modern dentistry, with roughly 2.5 million placed in the United States each year and success rates reaching 95% to 98% over a decade. As volume climbs with an aging population and full-arch cases increasingly performed under sedation, the documentation standard for implant surgery is rising with it.
Key Takeaways
- More than 1 million patients receive implants annually in the U.S., with about 2.5 million implants placed each year (American Academy of Implant Dentistry).
- Roughly 3 million Americans have implants, growing by about 500,000 patients per year.
- Success rates run 95% to 98% over 5 to 10 years, with ~82% survival at 15 years.
- Early failure occurs in about 2% to 3% of cases, usually from infection or failed osseointegration.
- Peri-implantitis affects roughly 19.5% of patients and 12.5% of implants (meta-analysis).
- A single implant typically costs $3,000 to $4,500; full-arch All-on-4 runs $20,000 to $35,000 per arch.
- 120 million Americans are missing at least one tooth and 36 million have none, a large unmet-need pool driving continued growth (American College of Prosthodontists).
- Full-arch and complex cases are frequently sedated, and every sedated implant case carries the same monitoring and documentation obligations as any other.
What's in This Guide
Implant Volume and Adoption
The scale of implant dentistry has grown dramatically in a generation. According to the American Academy of Implant Dentistry, more than 1 million patients receive implant treatment each year in the United States, translating to roughly 2.5 million individual implants placed annually. Adoption has climbed steeply: national prevalence data shows implant use rose from about 0.7% of the population in 1999-2000 to 5.7% in 2015-2016.
That growth is expected to continue through the early 2030s, driven by an aging population, better surgical techniques, digital and guided-surgery workflows, and expanding financing options. Notably, only about 10% of general dentists place implants regularly, with the majority referring to specialists such as oral surgeons and periodontists, which concentrates a large share of this volume in surgical practices.
Source: American Academy of Implant Dentistry data (compiled)
See how SedationVault documents surgical casesSuccess and Survival Rates
Implants earn their reputation on outcomes. In healthy patients, success rates run high and stay high for years before the gradual decline expected of any long-term restoration.
Within 5 to 10 years, success generally ranges from 95% to 98%. A retrospective study in Clinical and Experimental Dental Research reported 98.4% survival for implants placed immediately after extraction and 98.6% for those in fully healed sites. Over longer horizons, outcomes remain favorable but decline gradually, with one large retrospective study reporting an 82.6% survival rate at 15 years, reflecting aging, maintenance patterns, and patient health over time. All-on-4 full-arch solutions report prosthetic survival as high as 98.8%.
iSedate Analysis: Implants at risk from early failure
Formula: 2% to 3% early failure rate applied to ~2.5 million implants placed annually.
Applying the commonly cited 2% to 3% early failure rate to the roughly 2.5 million implants placed each year implies on the order of 50,000 to 75,000 early failures annually in the U.S. Each one is a clinical event that benefits from a documented record of placement conditions, patient risk factors, and, where sedation was used, the anesthesia course. High success does not eliminate the need for a defensible chart; it just means the chart matters most in the small fraction of cases that do not go to plan.
Sources: early failure rate from implant survival literature; annual volume from AAID. Calculation and interpretation original to iSedate.
Source: Implant survival data (compiled from clinical studies)
Full oral surgery complication dataFailure and Peri-Implantitis
When implants fail, the causes cluster into biological and mechanical categories, and the dominant biological threat is peri-implantitis, an inflammatory condition affecting the tissue and bone around the implant.
A systematic review and meta-analysis reported peri-implantitis prevalence of approximately 19.53% at the patient level and 12.53% at the implant level. Early failure, typically in the first months before osseointegration completes, occurs in about 2% to 3% of cases and usually stems from infection or failure to integrate with the bone. Known risk factors that raise failure rates include a history of periodontitis, smoking, uncontrolled diabetes, and insufficient bone density. Implants in the lower jaw generally outperform those in the upper jaw.
Myth: "Implants are permanent, so the paperwork ends at placement." Peri-implantitis affecting roughly one in five patients tells a different story. Implant success depends on patient selection, technique, and long-term maintenance, and when a failure is disputed, the record of the pre-operative assessment (bone density, periodontal history, smoking status), the placement, and any sedation used is what establishes that the standard of care was met. The high success rate is the reason to document carefully, not a reason to skip it.
Source: Peri-implantitis meta-analysis (compiled)
Document risk factors and consentCost and Market Size
Implants are a significant investment for patients and a large, growing market for the profession. Per-tooth cost varies widely by geography, materials, and whether adjunct procedures like bone grafting are needed.
A single implant commonly runs $3,000 to $4,500, with the broader range spanning roughly $1,500 to $6,000 depending on case complexity. Full-arch All-on-4 restorations range from $20,000 to $35,000 per arch. Titanium remains the dominant material at roughly 90% to 95% of implants worldwide, prized for biocompatibility and osseointegration, while zirconia is the fastest-growing segment.
Market-size estimates vary considerably by source and scope (U.S. versus global, device-only versus total procedure spend), so they are best read as a range. Independent analyses place the U.S. dental implant device market somewhere in the low single-digit billions of dollars in 2025, with consistent projected growth at compound annual rates generally in the 5% to 10% band through the early 2030s. The direction is unambiguous even where the exact figures differ: sustained, demographically driven growth.
Source: Grand View Research (dental implants market) | Fortune Business Insights
Compare SedationVault plans and pricingUnmet Need and Demographics
The growth runway is defined by how many people still need tooth replacement. The American College of Prosthodontists reports that 120 million Americans are missing at least one tooth and more than 36 million have no teeth at all, a vast pool against which current implant adoption is still modest.
The aging population is the primary driver: as the 65-and-older cohort expands, demand for fixed tooth replacement rises with it. Roughly 13% of implants go to patients aged 65 to 74, and only about a quarter of the edentulous population currently uses implants, underscoring both the clinical need and the persistent cost and access barriers. For surgical practices, this demographic wave means more implant volume, more medically complex older patients, and more cases where sedation and careful risk assessment come into play.
Source: American College of Prosthodontists data (compiled)
Built for surgical practicesImplants, Sedation, and Documentation
Not every implant is a sedation case, and it is important to be accurate about that. Many single implants are placed comfortably under local anesthesia alone. But sedation is common in the situations that are growing fastest: anxious patients, medically complex older adults, cases involving bone grafting or sinus lifts, and full-arch All-on-4 procedures that place multiple implants in one long visit.
When an implant case is sedated, it carries exactly the same monitoring and documentation obligations as any other sedation procedure: pre-sedation assessment, continuous vitals, consent, and a complete record. Full-arch cases in particular can be lengthy procedures on older patients with cardiac, respiratory, or metabolic comorbidities, precisely the population where closed-claim data shows anesthesia risk concentrates.
Where iSedate's SedationVault fits. For the implant cases that do involve sedation, especially full-arch and medically complex ones, SedationVault provides the complete record the procedure demands. It captures the pre-sedation assessment and ASA classification, feeds live vitals from compatible monitors (Edan, MindRay, Criticare, and more) into a timestamped sedation record, stores digital intake and consent, and generates one-click, audit-ready PDF reports. Its Sedation Intelligence System adds drug inventory, logs, license and certification tracking, and board-ready reporting, so a busy implant practice can prove its safety on every sedated case, not just describe it.
Source: Implant procedure and osseointegration data (compiled)
Book a SedationVault demoDental Implant Statistics: Summary Table
| Statistic | Figure | Source | Year |
|---|---|---|---|
| Patients receiving implants/year (U.S.) | 1 million+ | American Academy of Implant Dentistry | 2026 |
| Individual implants placed/year | ~2.5 million | American Academy of Implant Dentistry | 2026 |
| Americans who have implants | ~3 million | AAID (compiled) | 2026 |
| New implant patients/year | ~500,000 | AAID (compiled) | 2026 |
| Implant prevalence (2015–2016) | 5.7% | NHANES prevalence study | 2016 |
| Success rate, 5–10 years | 95%–98% | Clinical literature | 2026 |
| Survival at 15 years | ~82.6% | Retrospective study | 2026 |
| Immediate-placement survival | 98.4% | Clin. Exp. Dent. Res. | 2026 |
| Early failure rate | 2%–3% | Implant survival literature | 2026 |
| Peri-implantitis (patient level) | ~19.53% | Systematic review / meta-analysis | 2026 |
| Peri-implantitis (implant level) | ~12.53% | Systematic review / meta-analysis | 2026 |
| Single implant cost | $3,000–$4,500 | Commercial pricing data | 2026 |
| All-on-4 full arch (per arch) | $20,000–$35,000 | Commercial pricing data | 2026 |
| Titanium share of implants | ~90%–95% | Market research | 2025 |
| Americans missing 1+ tooth | 120 million | American College of Prosthodontists | 2026 |
| Americans with no teeth | 36 million+ | American College of Prosthodontists | 2026 |
| Osseointegration time | 3–6 months | Clinical literature | 2026 |
Frequently Asked Questions
How many dental implants are placed each year in the United States?
What is the success rate of dental implants?
How much does a dental implant cost in 2026?
What is peri-implantitis and how common is it?
Do dental implants require sedation?
Methodology & Sources
Volume and adoption figures are from the American Academy of Implant Dentistry and national prevalence data (NHANES). Success, survival, and failure rates are drawn from clinical and retrospective studies, including data reported in Clinical and Experimental Dental Research, and a systematic review and meta-analysis for peri-implantitis prevalence. Unmet-need figures are from the American College of Prosthodontists. Cost figures reflect 2026 U.S. commercial pricing data expressed as ranges. Market-size figures vary substantially across research firms depending on scope (U.S. versus global, device-only versus total spend) and are therefore presented as ranges with direction rather than a single point estimate. Where a figure derives from combining two sources, it is labeled as an iSedate Analysis with its inputs shown. Cost and market figures are informational, not quotes or investment advice.
Media and press usage: Journalists and researchers are welcome to cite the statistics in this article with attribution to the original primary sources named above, and to iSedate for any analysis labeled as original. A link back to this page is appreciated.
This article is an informational statistical overview and is not medical, financial, or investment advice. Cost and market figures are ranges, and clinical rates are population estimates, not individual predictions.
